Skip to main content
Sernova Biotherapeutics Inc (TSX:SVA)
Canada flag Canada · Delayed Price · Currency is CAD
0.170
0.00 (0.00%)
Apr 28, 2026, 2:57 PM EST

Sernova Biotherapeutics Cash Flow Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
 TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21 2020 - 2016
Net Income
-12.38-15.74-32.19-39-24.42-6.97
Upgrade
Depreciation & Amortization
0.30.340.540.450.440.27
Upgrade
Loss (Gain) From Sale of Assets
-0.06-0.06-0.02---
Upgrade
Stock-Based Compensation
2.192.511.753.97.450.22
Upgrade
Other Operating Activities
0.540.31-0.13-0.68-0.84-0.88
Upgrade
Change in Accounts Receivable
0.250.180.560.23-0.2-0.09
Upgrade
Change in Accounts Payable
1.621.5410.594.753.310.46
Upgrade
Change in Other Net Operating Assets
0.410.020.010-0.160.14
Upgrade
Operating Cash Flow
-7.13-10.91-18.9-30.34-14.42-6.84
Upgrade
Capital Expenditures
----0.1-0.33-0.02
Upgrade
Sale of Property, Plant & Equipment
0.020.02----
Upgrade
Investment in Securities
--11.0834.92-46-
Upgrade
Other Investing Activities
--0.04-0.04-0.01-0.21
Upgrade
Investing Cash Flow
0.020.0211.1234.78-46.34-0.23
Upgrade
Long-Term Debt Issued
-4.94----
Upgrade
Long-Term Debt Repaid
--0.11-0.17-0.17-0.17-0.03
Upgrade
Net Debt Issued (Repaid)
4.864.82-0.17-0.17-0.17-0.03
Upgrade
Issuance of Common Stock
1.550.275.23-36.5527.55
Upgrade
Other Financing Activities
0.060.050.010.680.283.47
Upgrade
Financing Cash Flow
6.475.145.070.536.6631
Upgrade
Net Cash Flow
-0.63-5.75-2.714.95-24.123.92
Upgrade
Free Cash Flow
-7.13-10.91-18.9-30.44-14.75-6.86
Upgrade
Free Cash Flow Per Share
-0.02-0.03-0.06-0.10-0.05-0.03
Upgrade
Cash Income Tax Paid
0.010.01----
Upgrade
Levered Free Cash Flow
-3.98-5.66-6.65-16.13-5.56-3.19
Upgrade
Unlevered Free Cash Flow
-3.35-5.19-6.29-16.11-5.53-3.18
Upgrade
Change in Working Capital
2.291.7411.164.992.950.52
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.